![]() |
Triple Drug Combination Is Promising Option To Treat Metastatic HER2+ Breast Cancer
Combining two chemotherapy drugs with trastuzumab (Herceptin) to treat women who have metastatic HER2+ breast cancer may offer physicians another choice in their treatment options.
More... |
| All times are GMT -7. The time now is 09:55 PM. |
Powered by vBulletin® Version 3.8.7
Copyright ©2000 - 2026, vBulletin Solutions, Inc.
Copyright HER2 Support Group 2007 - 2021